Newsroom

JDRF, our partners and our research funding make headlines. Read about our leading role in breakthrough advances that improve lives for people with type 1 diabetes (T1D).

Recent Press Releases

JDRF Statement on CDC Update of Covid-19 Prioritization Guidelines

March 30, 2021

Read More about JDRF Statement on CDC Update of Covid-19 Prioritization Guidelines
JDRF, Lupus Research Alliance and National Multiple Sclerosis Society Join Forces to Decode Common Mechanisms of Autoimmune Diseases

February 24, 2021

Read More about JDRF, Lupus Research Alliance and National Multiple Sclerosis Society Join Forces to Decode Common Mechanisms of Autoimmune Diseases
JDRF Announces New Center of Excellence in New England to Advance Type 1 Diabetes Research

February 23, 2021

Read More about JDRF Announces New Center of Excellence in New England to Advance Type 1 Diabetes Research
JDRF Statement on Delay of Regulation Eliminating Current System of Drug Rebates in Medicare Part D

January 29, 2021

Read More about JDRF Statement on Delay of Regulation Eliminating Current System of Drug Rebates in Medicare Part D
JDRF Official Statement: Authorization of First COVID-19 Vaccine

December 11, 2020

Read More about JDRF Official Statement: Authorization of First COVID-19 Vaccine

View All

Newsroom

Recent Press Releases

JDRF Statement on CDC Update of Covid-19 Prioritization Guidelines

JDRF, Lupus Research Alliance and National Multiple Sclerosis Society Join Forces to Decode Common Mechanisms of Autoimmune Diseases

JDRF Announces New Center of Excellence in New England to Advance Type 1 Diabetes Research

JDRF Statement on Delay of Regulation Eliminating Current System of Drug Rebates in Medicare Part D

JDRF Official Statement: Authorization of First COVID-19 Vaccine

Your privacy